Upadacitinib hemihydrate
規格
2050057-56-0CAS番号
bis((3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide);hydrateIUPAC名
C34H40F6N12O3化学式
778.8 g/mol分子量
Upadacitinib hemihydrate; 2050057-56-0; RINVOQ LQ; NEW4DV02U5; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-E)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-; RefChem:1100658; Rinvoq; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1); Upadacitinib hydrate (JAN); (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate; UPADACITINIB HYDRATE [JAN]; upadacitinib hydrate; Rinvoq (TN); UNII-NEW4DV02U5; Upadacitinib (as hemihydrate); CHEMBL5315119; EBC-134021; UPADACITINIB HEMIHYDRATE [WHO-DD]; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;hydrate; AC-37935; AS-97188; D11048; H53955; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate (2:1); 1831899-73-0; bis((3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide);hydrate; rel-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1)別名
Upadacitinib hemihydrateを含む製品
린버크서방정30밀리그램(유파다시티닙반수화물)린버크서방정15밀리그램(유파다시티닙반수화물)RINVOQ 30 MG COMPRIMIDOS DE LIBERACION PROLONGADARINVOQ 45 MG COMPRIMIDOS DE LIBERACION PROLONGADARINVOQ 30 MG COMPRIMIDOS DE LIBERACION PROLONGADARINVOQ 15 MG COMPRIMIDOS DE LIBERACION PROLONGADARINVOQ 45 mg, comprimé à libération prolongéeRINVOQ 30 mg, comprimé à libération prolongéeRINVOQ 15 mg, comprimé à libération prolongéeUpadacitinib hemihydrate CAS:2050057-56-0Upadacitinib HemihydrateUpadacitinib Hemihydrate
1/2ページ
Upadacitinib hemihydrateを販売する企業
AD
Abbvie Deutschland GmbH & Co. KGGermanySD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaZH
Zhejiang Huayi Pharmaceutical Co., Ltd.China한국
한국애브비(주)Republic of KoreaBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaJX
Jinan Xinnuo Pharmaceutical Co., LtdChina